PT891371E - Derivados 9-oxima-sililo da eritromicina a - Google Patents

Derivados 9-oxima-sililo da eritromicina a

Info

Publication number
PT891371E
PT891371E PT97905826T PT97905826T PT891371E PT 891371 E PT891371 E PT 891371E PT 97905826 T PT97905826 T PT 97905826T PT 97905826 T PT97905826 T PT 97905826T PT 891371 E PT891371 E PT 891371E
Authority
PT
Portugal
Prior art keywords
derivatives
erythromycin
silillus
oxym
alkylerythromycin
Prior art date
Application number
PT97905826T
Other languages
English (en)
Portuguese (pt)
Inventor
Yi-Yin Ku
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24510750&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT891371(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of PT891371E publication Critical patent/PT891371E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT97905826T 1996-04-02 1997-02-06 Derivados 9-oxima-sililo da eritromicina a PT891371E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/626,524 US5837829A (en) 1996-04-02 1996-04-02 9-oximesilyl erythromycin a derivatives

Publications (1)

Publication Number Publication Date
PT891371E true PT891371E (pt) 2004-04-30

Family

ID=24510750

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97905826T PT891371E (pt) 1996-04-02 1997-02-06 Derivados 9-oxima-sililo da eritromicina a

Country Status (10)

Country Link
US (1) US5837829A (enExample)
EP (1) EP0891371B1 (enExample)
JP (2) JP2000507574A (enExample)
AT (1) ATE256138T1 (enExample)
CA (1) CA2250771C (enExample)
DE (1) DE69726714T2 (enExample)
DK (1) DK0891371T3 (enExample)
ES (1) ES2212808T3 (enExample)
PT (1) PT891371E (enExample)
WO (1) WO1997036913A1 (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0915899T3 (da) 1996-07-29 2004-11-29 Abbott Lab Fremstilling af krystallinsk form II af clarithromycin
US5858986A (en) 1996-07-29 1999-01-12 Abbott Laboratories Crystal form I of clarithromycin
US5945405A (en) 1997-01-17 1999-08-31 Abbott Laboratories Crystal form O of clarithromycin
US20080050367A1 (en) 1998-04-07 2008-02-28 Guriq Basi Humanized antibodies that recognize beta amyloid peptide
AU2274799A (en) * 1997-12-22 1999-07-12 Biochemie S.A. Intermediates in macrolide production
KR100283990B1 (ko) * 1998-12-29 2001-03-02 민경윤 에리스로마이신 a 유도체 및 그의 제조방법
US6437106B1 (en) 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
GB9915745D0 (en) * 1999-07-06 1999-09-08 Biochemie Sa Organic compounds
YU45602A (sh) * 1999-12-16 2005-06-10 Teva Pharmaceutical Industries Ltd. Postupci za dobijanje polimorfa klaritromicina i novi polimorf iv
DE60018119T2 (de) * 2000-01-11 2006-05-04 Teva Pharmaceutical Industries Ltd. Verfahren zur herstellung von polymorphen des clarithromycins
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
CA2401571A1 (en) * 2000-02-29 2001-09-07 Ilya Avrutov Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same
ES2242668T3 (es) * 2000-03-15 2005-11-16 Hanmi Pharm. Co., Ltd. Metodo para obtener claritromicina en cristales de forma ii.
KR100367981B1 (ko) * 2000-11-23 2003-01-14 한미약품공업 주식회사 클라리스로마이신 결정형 2의 제조 방법 및 이 방법에사용되는 결정성 클라리스로마이신 메실레이트 삼수화물
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
AU2004258953B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
JP2006528185A (ja) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
AU2004258949B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
JP2007502296A (ja) 2003-08-11 2007-02-08 アドバンシス ファーマスーティカル コーポレイション ロバストペレット
EP1653924A4 (en) 2003-08-12 2009-09-09 Middlebrook Pharmaceuticals In ANTIBIOTICS, USE AND FORMULATION ASSOCIATED
CA2535780A1 (en) * 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
CA2538064C (en) 2003-09-15 2013-12-17 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
JP2008505124A (ja) 2004-07-02 2008-02-21 アドバンシス ファーマスーティカル コーポレイション パルス送達用錠剤
US20060111560A1 (en) * 2004-11-01 2006-05-25 Glenmark Pharmaceuticals Limited Process for the preparation of crystalline form II of clarithromycin
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8784810B2 (en) 2006-04-18 2014-07-22 Janssen Alzheimer Immunotherapy Treatment of amyloidogenic diseases
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
US8613920B2 (en) 2007-07-27 2013-12-24 Janssen Alzheimer Immunotherapy Treatment of amyloidogenic diseases
US20090054634A1 (en) * 2007-08-09 2009-02-26 Vinod Kumar Kansal Process for the preparation of clarithromycin
JO3076B1 (ar) 2007-10-17 2017-03-15 Janssen Alzheimer Immunotherap نظم العلاج المناعي المعتمد على حالة apoe
US9067981B1 (en) 2008-10-30 2015-06-30 Janssen Sciences Ireland Uc Hybrid amyloid-beta antibodies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670549A (en) * 1985-03-18 1987-06-02 Taisho Pharmaceutical Co., Ltd. Method for selective methylation of erythromycin a derivatives
US4640910A (en) * 1985-11-12 1987-02-03 Abbott Laboratories Erythromycin A silylated compounds and method of use
DE3782994T2 (de) * 1986-09-18 1993-04-08 Taisho Pharma Co Ltd Erythromycin-a-derivate und verfahren zu ihrer herstellung.
KR960000434B1 (ko) * 1986-12-17 1996-01-06 다이쇼 세이야꾸 가부시끼가이샤 에리스로마이신 a유도체 및 그의 제조 방법

Also Published As

Publication number Publication date
JP2000507574A (ja) 2000-06-20
ATE256138T1 (de) 2003-12-15
DE69726714T2 (de) 2004-10-07
DE69726714D1 (en) 2004-01-22
CA2250771A1 (en) 1997-10-09
WO1997036913A1 (en) 1997-10-09
DK0891371T3 (da) 2004-04-13
JP2007224035A (ja) 2007-09-06
EP0891371A1 (en) 1999-01-20
ES2212808T3 (es) 2004-08-01
CA2250771C (en) 2006-05-02
US5837829A (en) 1998-11-17
EP0891371B1 (en) 2003-12-10

Similar Documents

Publication Publication Date Title
PT891371E (pt) Derivados 9-oxima-sililo da eritromicina a
ES2191982T3 (es) Derivados de 6-o-alquilo de eritronolida b.
NO176823C (no) Fremgangsmåte for fremstilling av fermentert soyasaus
FI906083A7 (fi) Foerbaettringar i cyklopeptidderivat och beroerande dessa.
AU7596587A (en) Benzimidazole derivatives
NO872831L (no) FremgangsmŸte for fremstilling av nitrofuranderivater.
NO913745L (no) Fremgangsmaate for fremstilling av 1,3-benzoksazinderivater
AU6867487A (en) Benzimidazole derivatives
NO901070L (no) Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater.
TR23145A (tr) Diflufenican kullanan herbisidal usul
AU7703887A (en) Tube expander
KR970702922A (ko) 독소루비신의 제조방법(Process for preparing doxorubicin)
NO901071D0 (no) Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater.
AU8204887A (en) Conjugate vaccine
AU7216287A (en) Benzimidazole derivatives
DE3886203D1 (de) Prozessor-Prozessor-Synchronisierung.
NO871759D0 (no) Fremgangsmaate for fremstilling av sucralfat-preparater.
NO893713D0 (no) Fremgangsmaate for fremstilling av benzoksazolon-derivater.
DE59003497D1 (de) Verdoppelte Reaktivfarbstoffe.
ZA891242B (en) 24r-scymnol,and preparation and use thereof
NO894016L (no) Ultramild toalettsaape og fremgangsmaate for fremstilling av saapen.
NO961429D0 (no) Fremgangsmåte for fremstilling av kinolonholdige, orale preparater
DE68918639D1 (de) Färbehilfsmittelzusammensetzung und Färbeverfahren.
AU6679490A (en) Dye couplers
NO890216D0 (no) Fremgangsmaate for revitalisering av forstkulturer.